{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:10:10Z","timestamp":1793682610861,"version":"4.5.1"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41585-025-01044-4","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T14:01:32Z","timestamp":1747317692000},"page":"672-686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pathophysiology and potential multimodal therapeutic strategies for IC\/BPS"],"prefix":"10.1038","volume":"22","author":[{"given":"Jia-Fong","family":"Jhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ru","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-4771","authenticated-orcid":false,"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"1044_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/JU.0000000000002756","volume":"208","author":"JQ Clemens","year":"2022","unstructured":"Clemens, J. Q., Erickson, D. R., Varela, N. P. & Lai, H. H. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. J. Urol. 208, 34\u201342 (2022). This article describes AUA guidelines for the diagnosis and treatment of IC\/BPS, clearly defining IC\/BPS as different subgroups or phenotypes and recommending multimodal therapies that depend on the clinical characteristics and urological findings.","journal-title":"J. Urol."},{"key":"1044_CR2","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/iju.13118","volume":"23","author":"Y Homma","year":"2016","unstructured":"Homma, Y. et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015. Int. J. Urol. 23, 542\u2013549 (2016).","journal-title":"Int. J. Urol."},{"key":"1044_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","volume":"193","author":"PM Hanno","year":"2015","unstructured":"Hanno, P. M., Erickson, D., Moldwin, R., Faraday, M. M. & American Urological Association. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment. J. Urol. 193, 1545\u20131553 (2015).","journal-title":"J. Urol."},{"key":"1044_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/iju.13969","volume":"26","author":"Y Akiyama","year":"2019","unstructured":"Akiyama, Y. & Hanno, P. Phenotyping of interstitial cystitis\/bladder pain syndrome. Int. J. Urol. 26, 17\u201319 (2019).","journal-title":"Int. J. Urol."},{"key":"1044_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/iju.14234","volume":"27","author":"Y Homma","year":"2020","unstructured":"Homma, Y. et al. Clinical guidelines for interstitial cystitis\/bladder pain syndrome. Int. J. Urol. 27, 578\u2013589 (2020).","journal-title":"Int. J. Urol."},{"key":"1044_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/tcmj.tcmj_172_23","volume":"36","author":"WR Yu","year":"2024","unstructured":"Yu, W. R., Jiang, Y. H., Jhang, J. F. & Kuo, H. C. Cystoscopic characteristic findings of interstitial cystitis and clinical implications. Tzu Chi Med. J. 36, 30\u201337 (2024). This article presents the figures for Hunner lesions and description of different mucosal lesions after cystoscopic hydrodistension and clearly defines IC\/BPS phenotypes according to characteristic cystoscopic findings.","journal-title":"Tzu Chi Med. J."},{"key":"1044_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/JU.0000000000001334","volume":"205","author":"JF Jhang","year":"2021","unstructured":"Jhang, J. F., Hsu, Y. H., Jiang, Y. H., Ho, H. C. & Kuo, H. C. Clinical relevance of bladder histopathological findings and their impact on treatment outcomes among patients with interstitial cystitis\/bladder pain syndrome: an investigation of the European Society for the Study of Interstitial Cystitis histopathological classification. J. Urol. 205, 226\u2013235 (2021). This article reports the association between bladder histopathology and clinical parameters and treatment outcomes in patients with IC\/BPS and reveals that patients with no remarkable bladder histopathological findings might have less favourable treatment outcomes.","journal-title":"J. Urol."},{"key":"1044_CR8","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3390\/biomedicines10051149","volume":"10","author":"WR Yu","year":"2022","unstructured":"Yu, W. R., Jiang, Y. H., Jhang, J. F. & Kuo, H. C. Use of urinary cytokine and chemokine levels for identifying bladder conditions and predicting treatment outcomes in patients with interstitial cystitis\/bladder pain syndrome. Biomedicines 10, 1149 (2022).","journal-title":"Biomedicines"},{"key":"1044_CR9","volume":"10","author":"MS Rahnama\u2019I","year":"2020","unstructured":"Rahnama\u2019I, M. S. et al. Bladder pain syndrome and interstitial cystitis beyond horizon: reports from the Global Interstitial Cystitis\/Bladder Pain Society (GIBS) meeting 2019 Mumbai\u00a0\u2014 India. Anesth. Pain Med. 10, e101848 (2020).","journal-title":"Anesth. Pain Med."},{"key":"1044_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/iju.14229","volume":"27","author":"Y Akiyama","year":"2020","unstructured":"Akiyama, Y., Luo, Y., Hanno, P. M., Maeda, D. & Homma, Y. Interstitial cystitis\/bladder pain syndrome: the evolving landscape, animal models and future perspectives. Int. J. Urol. 27, 491\u2013503 (2020).","journal-title":"Int. J. Urol."},{"key":"1044_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","volume":"53","author":"JP van de Merwe","year":"2008","unstructured":"van de Merwe, J. P. et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: an ESSIC proposal. Eur. Urol. 53, 60\u201367 (2008).","journal-title":"Eur. Urol."},{"key":"1044_CR12","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.juro.2006.11.084","volume":"177","author":"JQ Clemens","year":"2007","unstructured":"Clemens, J. Q. et al. Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. J. Urol. 177, 1390\u20131394 (2007).","journal-title":"J. Urol."},{"key":"1044_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.eururo.2006.08.028","volume":"51","author":"C Temml","year":"2007","unstructured":"Temml, C. et al. Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. Eur. Urol. 51, 803\u2013808 (2007).","journal-title":"Eur. Urol."},{"key":"1044_CR14","doi-asserted-by":"publisher","first-page":"925834","DOI":"10.3389\/fpain.2022.925834","volume":"3","author":"JT Anger","year":"2022","unstructured":"Anger, J. T. et al. National prevalence of IC\/BPS in women and men utilizing veterans health administration data. Front. Pain Res. 3, 925834 (2022).","journal-title":"Front. Pain Res."},{"key":"1044_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/MOU.0000000000001158","volume":"34","author":"J Tornic","year":"2024","unstructured":"Tornic, J. & Engeler, D. Latest insights into the pathophysiology of bladder pain syndrome\/interstitial cystitis. Curr. Opin. Urol. 34, 84\u201388 (2024).","journal-title":"Curr. Opin. Urol."},{"key":"1044_CR16","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/nau.24958","volume":"41","author":"AD Dobberfuhl","year":"2022","unstructured":"Dobberfuhl, A. D. Pathophysiology, assessment, and treatment of overactive bladder symptoms in patients with interstitial cystitis\/bladder pain syndrome. Neurourol. Urodyn. 41, 1958\u20131966 (2022).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR17","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3390\/biomedicines10102380","volume":"10","author":"JF Jhang","year":"2022","unstructured":"Jhang, J. F., Jiang, Y. H. & Kuo, H. C. Current understanding of the pathophysiology and novel treatments of interstitial cystitis\/bladder pain syndrome. Biomedicines 10, 2380 (2022).","journal-title":"Biomedicines"},{"key":"1044_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.juro.2014.07.108","volume":"193","author":"JC Nickel","year":"2015","unstructured":"Nickel, J. C., Tripp, D. A. & International Interstitial Cystitis Study Group. Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis\/bladder pain syndrome. J. Urol. 193, 138\u2013144 (2015).","journal-title":"J. Urol."},{"key":"1044_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/iju.13971","volume":"26","author":"KE Whitmore","year":"2019","unstructured":"Whitmore, K. E. et al. Hunner lesion versus non-Hunner lesion interstitial cystitis\/bladder pain syndrome. Int. J. Urol. 26, 26\u201334 (2019).","journal-title":"Int. J. Urol."},{"key":"1044_CR20","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.5213\/inj.1632712.356","volume":"20","author":"JF Jhang","year":"2016","unstructured":"Jhang, J. F. & Kuo, H. C. Pathomechanism of interstitial cystitis\/bladder pain syndrome and mapping the heterogeneity of disease. Int. Neurourol. J. 20, S95\u2013S104 (2016).","journal-title":"Int. Neurourol. J."},{"key":"1044_CR21","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/ijcp.12116","volume":"67","author":"YC Kuo","year":"2013","unstructured":"Kuo, Y. C. & Kuo, H. C. The urodynamic characteristics and prognostic factors of patients with interstitial cystitis\/bladder pain syndrome. Int. J. Clin. Pract. 67, 863\u2013869 (2013).","journal-title":"Int. J. Clin. Pract."},{"key":"1044_CR22","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/nau.23542","volume":"37","author":"YC Kuo","year":"2018","unstructured":"Kuo, Y. C. & Kuo, H. C. Videourodynamic characteristics of interstitial cystitis\/bladder pain syndrome \u2014 the role of bladder outlet dysfunction in the pathophysiology. Neurourol. Urodyn. 37, 1971\u20131977 (2018).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151692","volume":"11","author":"YH Jiang","year":"2016","unstructured":"Jiang, Y. H., Jhang, J. F. & Kuo, H. C. Revisiting the role of potassium sensitivity testing and cystoscopic hydrodistention for the diagnosis of interstitial cystitis. PLoS ONE 11, e0151692 (2016).","journal-title":"PLoS ONE"},{"key":"1044_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14372","volume":"75","author":"WR Yu","year":"2021","unstructured":"Yu, W. R., Chang, W. C. & Kuo, H. C. Voiding dysfunctions in patients with non-Hunner\u2019s ulcer interstitial cystitis\/bladder pain syndrome do not affect long-term treatment outcome. Int. J. Clin. Pract. 75, e14372 (2021).","journal-title":"Int. J. Clin. Pract."},{"key":"1044_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.juro.2015.06.112","volume":"195","author":"GE Wennevik","year":"2016","unstructured":"Wennevik, G. E., Meijlink, J. M., Hanno, P. & Nordling, J. The role of glomerulations in bladder pain syndrome: a review. J. Urol. 195, 19\u201325 (2016).","journal-title":"J. Urol."},{"key":"1044_CR26","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3390\/diagnostics11122298","volume":"11","author":"RA Towner","year":"2021","unstructured":"Towner, R. A., Smith, N., Saunders, D. & Hurst, R. E. MRI as a tool to assess interstitial cystitis associated bladder and brain pathologies. Diagnostics 11, 2298 (2021).","journal-title":"Diagnostics"},{"key":"1044_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.urology.2007.02.067","volume":"70","author":"KM Peters","year":"2007","unstructured":"Peters, K. M. et al. Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology 70, 16\u201318 (2007).","journal-title":"Urology"},{"key":"1044_CR28","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.juro.2017.03.132","volume":"198","author":"HH Lai","year":"2017","unstructured":"Lai, H. H. et al. Characterization of whole body pain in urological chronic pelvic pain syndrome at baseline: a Mapp Research Network Study. J. Urol. 198, 622\u2013631 (2017).","journal-title":"J. Urol."},{"key":"1044_CR29","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.juro.2014.10.086","volume":"193","author":"JN Krieger","year":"2015","unstructured":"Krieger, J. N. et al. Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the Mapp Study. J. Urol. 193, 1254\u20131262 (2015).","journal-title":"J. Urol."},{"key":"1044_CR30","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.juro.2017.05.065","volume":"198","author":"BD Naliboff","year":"2017","unstructured":"Naliboff, B. D. et al. Clinical and psychosocial predictors of urological chronic pelvic pain symptom change in 1 year: a prospective study from the mapp research network. J. Urol. 198, 848\u2013857 (2017).","journal-title":"J. Urol."},{"key":"1044_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/iju.12311","volume":"21","author":"HC Kuo","year":"2014","unstructured":"Kuo, H. C. Potential urine and serum biomarkers for patients with bladder pain syndrome\/interstitial cystitis. Int. J. Urol. 21, 34\u201341 (2014).","journal-title":"Int. J. Urol."},{"key":"1044_CR32","doi-asserted-by":"publisher","first-page":"12044","DOI":"10.3390\/ijms231912044","volume":"23","author":"YH Jiang","year":"2022","unstructured":"Jiang, Y. H., Jhang, J. F., Hsu, Y. H. & Kuo, H. C. Usefulness of urinary biomarkers for assessing bladder condition and histopathology in patients with interstitial cystitis\/bladder pain syndrome. Int. J. Mol. Sci. 23, 12044 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1044_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41585-023-00850-y","volume":"21","author":"A Mohammad","year":"2024","unstructured":"Mohammad, A., Laboulaye, M. A., Shenhar, C. & Dobberfuhl, A. D. Mechanisms of oxidative stress in interstitial cystitis\/bladder pain syndrome. Nat. Rev. Urol. 21, 433\u2013449 (2024).","journal-title":"Nat. Rev. Urol."},{"key":"1044_CR34","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.3390\/jcm12062336","volume":"12","author":"YH Jiang","year":"2023","unstructured":"Jiang, Y. H., Jhang, J. F. & Kuo, H. C. Urinary oxidative stress biomarker levels might be useful in identifying functional bladder disorders in women with frequency and urgency syndrome. J. Clin. Med. 12, 2336 (2023).","journal-title":"J. Clin. Med."},{"key":"1044_CR35","doi-asserted-by":"publisher","first-page":"12055","DOI":"10.3390\/ijms241512055","volume":"24","author":"WR Yu","year":"2023","unstructured":"Yu, W. R., Jiang, Y. H., Jhang, J. F. & Kuo, H. C. Use of urinary biomarkers in discriminating interstitial cystitis\/bladder pain syndrome from male lower urinary tract dysfunctions. Int. J. Mol. Sci. 24, 12055 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1044_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.urology.2021.05.005","volume":"157","author":"J Kim","year":"2021","unstructured":"Kim, J. et al. Diagnostic utility of serum and urinary metabolite analysis in patients with interstitial cystitis\/painful bladder syndrome. Urology 157, 85\u201392 (2021).","journal-title":"Urology"},{"key":"1044_CR37","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/JU.0000000000001031","volume":"204","author":"HH Lai","year":"2020","unstructured":"Lai, H. H., Pickersgill, N. A. & Vetter, J. M. Hunner lesion phenotype in interstitial cystitis\/bladder pain syndrome: a systematic review and meta-analysis. J. Urol. 204, 518\u2013523 (2020). This article describes HIC and NHIC as two distinct clinical phenotypes with substantial differences in demographics, clinical presentation, urinary marker profiles and treatment responses.","journal-title":"J. Urol."},{"key":"1044_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/luts.12344","volume":"13","author":"D Watanabe","year":"2021","unstructured":"Watanabe, D. et al. Clinical characterization of interstitial cystitis\/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations. Low. Urin. Tract Symptoms 13, 139\u2013143 (2021).","journal-title":"Low. Urin. Tract Symptoms"},{"key":"1044_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.urology.2021.07.009","volume":"158","author":"A Plair","year":"2021","unstructured":"Plair, A. et al. Anesthetic bladder capacity is a clinical biomarker for interstitial cystitis\/bladder pain syndrome subtypes. Urology 158, 74\u201380 (2021).","journal-title":"Urology"},{"key":"1044_CR40","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5213\/inj.1938110.055","volume":"23","author":"A Otsuka","year":"2019","unstructured":"Otsuka, A. et al. Therapeutic endoscopic treatment plus maintenance dimethyl sulfoxide therapy prolongs recurrence-free time in patients with Hunner type interstitial cystitis: a pilot Study. Int. Neurourol. J. 23, 327\u2013333 (2019).","journal-title":"Int. Neurourol. J."},{"key":"1044_CR41","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00192-023-05449-w","volume":"34","author":"R Taneja","year":"2023","unstructured":"Taneja, R. et al. Diagnostic and therapeutic cystoscopy in bladder pain syndrome\/interstitial cystitis: systematic review of literature and consensus on methodology. Int. Urogynecol. J. 34, 1165\u20131173 (2023).","journal-title":"Int. Urogynecol. J."},{"key":"1044_CR42","first-page":"25","volume":"34","author":"Y Akiyama","year":"2019","unstructured":"Akiyama, Y., Homma, Y. & Maeda, D. Pathology and terminology of interstitial cystitis\/bladder pain syndrome: a review. Histol. Histopathol. 34, 25\u201332 (2019).\u00a0","journal-title":"Histol. Histopathol."},{"key":"1044_CR43","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/biomedicines9101306","volume":"9","author":"JF Jhang","year":"2021","unstructured":"Jhang, J. F. et al. Possible association between bladder wall morphological changes on computed tomography and bladder-centered interstitial cystitis\/bladder pain syndrome. Biomedicines 9, 1306 (2021).","journal-title":"Biomedicines"},{"key":"1044_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/21681805.2020.1730948","volume":"54","author":"M Fall","year":"2020","unstructured":"Fall, M. et al. Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report. Scand. J. Urol. 54, 91\u201398 (2020).","journal-title":"Scand. J. Urol."},{"key":"1044_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80252-x","volume":"11","author":"WR Yu","year":"2021","unstructured":"Yu, W. R. et al. Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment. Sci. Rep. 11, 455 (2021).","journal-title":"Sci. Rep."},{"key":"1044_CR46","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3390\/biomedicines10051182","volume":"10","author":"YK Lee","year":"2022","unstructured":"Lee, Y. K., Jiang, Y. H., Jhang, J. F., Ho, H. C. & Kuo, H. C. Changes in the ultrastructure of the bladder urothelium in patients with interstitial cystitis after intravesical injections of platelet-rich plasma. Biomedicines 10, 1182 (2022).","journal-title":"Biomedicines"},{"key":"1044_CR47","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/toxins11110676","volume":"11","author":"HJ Wang","year":"2019","unstructured":"Wang, H. J., Yu, W. R., Ong, H. L. & Kuo, H. C. Predictive factors for a satisfactory treatment outcome with intravesical botulinum toxin A injection in patients with interstitial cystitis\/bladder pain syndrome. Toxins 11, 676 (2019).","journal-title":"Toxins"},{"key":"1044_CR48","first-page":"369","volume":"74","author":"C Guti\u00e9rrez-Ru\u00edz","year":"2021","unstructured":"Guti\u00e9rrez-Ru\u00edz, C. et al. UPOINT phenotypic classification of a sample of female patients with bladder pain syndrome: results of a National Multicentric Observational Study. Arch. Esp. Urol. 74, 369\u2013382 (2021).","journal-title":"Arch. Esp. Urol."},{"key":"1044_CR49","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.eururo.2012.05.023","volume":"62","author":"DA Tripp","year":"2012","unstructured":"Tripp, D. A. et al. Mapping of pain phenotypes in female patients with bladder pain syndrome\/interstitial cystitis and controls. Eur. Urol. 62, 1188\u20131194 (2012).","journal-title":"Eur. Urol."},{"key":"1044_CR50","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/j.pain.0000000000003455","volume":"166","author":"JT Farrar","year":"2025","unstructured":"Farrar, J. T. et al. Widespread pain phenotypes impact treatment efficacy results in randomized clinical trials for interstitial cystitis\/bladder pain syndrome: a multidisciplinary approach to the study of Chronic Pelvic Pain Network Study. Pain 166, 1179\u20131190 (2025). This article describes the different pain presentations in IC\/BPS and compares therapies targeting local bladder symptoms and therapies targeting widespread (systemic) pain.","journal-title":"Pain"},{"key":"1044_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.urology.2014.03.001","volume":"84","author":"JC Nickel","year":"2014","unstructured":"Nickel, J. C., Irvine-Bird, K., Jianbo, L. & Shoskes, D. A. Phenotype-directed management of interstitial cystitis\/bladder pain syndrome. Urology 84, 175\u2013179 (2014).","journal-title":"Urology"},{"key":"1044_CR52","first-page":"9250","volume":"25","author":"A Crane","year":"2018","unstructured":"Crane, A., Lloyd, J. & Shoskes, D. A. Improving the utility of clinical phenotyping in interstitial cystitis\/painful bladder syndrome: from UPOINT to INPUT. Can. J. Urol. 25, 9250\u20139254 (2018).","journal-title":"Can. J. Urol."},{"key":"1044_CR53","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.5213\/inj.1835062.531","volume":"22","author":"L Birder","year":"2018","unstructured":"Birder, L. & Andersson, K. E. Animal modelling of interstitial cystitis\/bladder pain syndrome. Int. Neurourol. J. 22, S3\u2013S9 (2018).","journal-title":"Int. Neurourol. J."},{"key":"1044_CR54","doi-asserted-by":"publisher","first-page":"F174","DOI":"10.1152\/ajprenal.00290.2020","volume":"320","author":"Y Akiyama","year":"2021","unstructured":"Akiyama, Y. et al. Autoimmunity to urothelial antigen causes bladder inflammation, pelvic pain, and voiding dysfunction: a novel animal model for Hunner-type interstitial cystitis. Am. J. Physiol. Ren. Physiol. 320, F174\u2013F182 (2021).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1044_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198816","volume":"13","author":"JF Jhang","year":"2018","unstructured":"Jhang, J. F. et al. Electron microscopic characteristics of interstitial cystitis\/bladder pain syndrome and their association with clinical condition. PLoS ONE 13, e0198816 (2018).","journal-title":"PLoS ONE"},{"key":"1044_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ucl.2022.09.006","volume":"50","author":"JM Masterson","year":"2023","unstructured":"Masterson, J. M., Casta\u00f1eda, P. R. & Kim, J. Pathophysiology and clinical biomarkers in interstitial cystitis. Urol. Clin. North Am. 50, 39\u201352 (2023).","journal-title":"Urol. Clin. North Am."},{"key":"1044_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96810-w","volume":"11","author":"YK Lee","year":"2021","unstructured":"Lee, Y. K. et al. Difference in electron microscopic findings among interstitial cystitis\/bladder pain syndrome with distinct clinical and cystoscopic characteristics. Sci. Rep. 11, 17258 (2021). This article reports the electron microscopic findings in HIC and NHIC. Both groups demonstrated more severe lamina propria inflammatory cell infiltration than controls.","journal-title":"Sci. Rep."},{"key":"1044_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143316","volume":"10","author":"D Maeda","year":"2015","unstructured":"Maeda, D. et al. Hunner-type (classic) interstitial cystitis: a distinct inflammatory disorder characterized by pancystitis, with frequent expansion of clonal B-cells and epithelial denudation. PLoS ONE 10, e0143316 (2015).","journal-title":"PLoS ONE"},{"key":"1044_CR59","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/iju.14585","volume":"28","author":"JF Jhang","year":"2021","unstructured":"Jhang, J. F., Jiang, Y. H., Hsu, Y. H., Ho, H. C. & Kuo, H. C. Decreased urothelial cytoskeleton and cell proliferation protein expression suggest interstitial cystitis\/bladder pain syndrome patients with Hunner\u2019s lesion and grade 3 glomerulation might be different from other types of patients. Int. J. Urol. 28, 823\u2013830 (2021).","journal-title":"Int. J. Urol."},{"key":"1044_CR60","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1464-410X.1982.tb06976.x","volume":"54","author":"S Larsen","year":"1982","unstructured":"Larsen, S. et al. Mast cells in interstitial cystitis. Br. J. Urol. 54, 283\u2013286 (1982).","journal-title":"Br. J. Urol."},{"key":"1044_CR61","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/S0022-5347(17)43359-3","volume":"138","author":"WL Lynes","year":"1987","unstructured":"Lynes, W. L. et al. Mast cell involvement in interstitial cystitis. J. Urol. 138, 746\u2013752 (1987).","journal-title":"J. Urol."},{"key":"1044_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-019-0548-3","volume":"19","author":"H Shan","year":"2019","unstructured":"Shan, H. et al. Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome\/interstitial cystitis \u2014 significance in the responsiveness to antihistamine treatment and disease symptoms. BMC Urol. 19, 115 (2019).","journal-title":"BMC Urol."},{"key":"1044_CR63","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.juro.2014.04.099","volume":"192","author":"Y Logadottir","year":"2014","unstructured":"Logadottir, Y. et al. Cytokine expression in patients with bladder pain syndrome\/interstitial cystitis ESSIC type 3C. J. Urol. 192, 1564\u20131568 (2014).","journal-title":"J. Urol."},{"key":"1044_CR64","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/path.6040","volume":"259","author":"JF Jhang","year":"2023","unstructured":"Jhang, J. F. et al. EBV infection mediated BDNF expression is associated with bladder inflammation in interstitial cystitis\/bladder pain syndrome with Hunner\u2019s lesion. J. Pathol. 259, 276\u2013290 (2023).","journal-title":"J. Pathol."},{"key":"1044_CR65","doi-asserted-by":"publisher","first-page":"E136","DOI":"10.1111\/j.1464-410X.2010.09911.x","volume":"108","author":"JH Shie","year":"2011","unstructured":"Shie, J. H. & Kuo, H. C. Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis\/painful bladder syndrome. BJU Int. 108, E136\u2013E141 (2011).","journal-title":"BJU Int."},{"key":"1044_CR66","doi-asserted-by":"publisher","first-page":"101114","DOI":"10.1016\/j.xcrm.2023.101114","volume":"4","author":"Y Akiyama","year":"2023","unstructured":"Akiyama, Y. et al. Genome-wide association study identifies risk loci within the major histocompatibility complex region for Hunner-type interstitial cystitis. Cell Rep. Med. 4, 101114 (2023).","journal-title":"Cell Rep. Med."},{"key":"1044_CR67","doi-asserted-by":"publisher","first-page":"108262","DOI":"10.1016\/j.isci.2023.108262","volume":"26","author":"Y Akiyama","year":"2023","unstructured":"Akiyama, Y. et al. Th1\/17 polarization and potential treatment by an anti-interferon-\u03b3 DNA aptamer in Hunner-type interstitial cystitis. iScience 26, 108262 (2023).","journal-title":"iScience"},{"key":"1044_CR68","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1113\/JP274191","volume":"595","author":"ZC Danziger","year":"2017","unstructured":"Danziger, Z. C. & Grill, W. M. Sensory feedback from the urethra evokes state-dependent lower urinary tract reflexes in rat. J. Physiol. 595, 5687\u20135698 (2017).","journal-title":"J. Physiol."},{"key":"1044_CR69","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000355175","volume":"92","author":"BL Liu","year":"2014","unstructured":"Liu, B. L. et al. Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis\/bladder pain syndrome. Urol. Int. 92, 202\u2013208 (2014).","journal-title":"Urol. Int."},{"key":"1044_CR70","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/bph.16017","volume":"180","author":"S Ramsay","year":"2023","unstructured":"Ramsay, S., Keightley, L., Brookes, S. & Zagorodnyuk, V. TRPV1 and TRPM8 antagonists reduce cystitis-induced bladder hypersensitivity via inhibition of different sensitised classes of bladder afferents in guinea pigs. Br. J. Pharmacol. 180, 1482\u20131499 (2023).","journal-title":"Br. J. Pharmacol."},{"key":"1044_CR71","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65192","volume":"10","author":"V Zhemkov","year":"2021","unstructured":"Zhemkov, V. et al. The role of sigma 1 receptor in organization of endoplasmic reticulum signaling microdomains. eLife 10, e65192 (2021).","journal-title":"eLife"},{"key":"1044_CR72","doi-asserted-by":"publisher","first-page":"705575","DOI":"10.3389\/fphys.2021.705575","volume":"12","author":"R Aishwarya","year":"2021","unstructured":"Aishwarya, R., Abdullah, C. S., Morshed, M., Remex, N. S. & Bhuiyan, M. S. Sigmar1\u2019s molecular, cellular, and biological functions in regulating cellular pathophysiology. Front. Physiol. 12, 705575 (2021).","journal-title":"Front. Physiol."},{"key":"1044_CR73","doi-asserted-by":"publisher","first-page":"105339","DOI":"10.1016\/j.phrs.2020.105339","volume":"163","author":"MC Ruiz-Cantero","year":"2021","unstructured":"Ruiz-Cantero, M. C. et al. Sigma-1 receptor: a drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain. Pharmacol. Res. 163, 105339 (2021).","journal-title":"Pharmacol. Res."},{"key":"1044_CR74","doi-asserted-by":"publisher","first-page":"301.e1","DOI":"10.1016\/j.urology.2020.09.037","volume":"301","author":"L Wu","year":"2020","unstructured":"Wu, L., Zhang, J., Zhou, F. & Zhang, P. Increased transient receptor potential melastatin 8 expression in the development of bladder pain in patients with interstitial cystitis\/bladder pain syndrome. Urology 301, 301.e1\u2013301.e6 (2020).","journal-title":"Urology"},{"key":"1044_CR75","doi-asserted-by":"publisher","first-page":"104724","DOI":"10.1016\/j.phrs.2020.104724","volume":"155","author":"R Gonz\u00e1lez-Cano","year":"2020","unstructured":"Gonz\u00e1lez-Cano, R. et al. Urinary bladder sigma-1 receptors: a new target for cystitis treatment. Pharmacol. Res. 155, 104724 (2020).","journal-title":"Pharmacol. Res."},{"key":"1044_CR76","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.2147\/JPR.S343695","volume":"14","author":"G Deutsch","year":"2021","unstructured":"Deutsch, G., Deshpande, H., Lai, H. H., Kutch, J. J. & Ness, T. J. Cerebral perfusion and sensory testing results differ in interstitial cystitis\/bladder pain syndrome patients with and without fibromyalgia: a site-specific MAPP Network Study. J. Pain Res. 14, 3887\u20133895 (2021).","journal-title":"J. Pain Res."},{"key":"1044_CR77","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.juro.2013.11.099","volume":"191","author":"HH Lai","year":"2014","unstructured":"Lai, H. H., Gardner, V., Ness, T. J. & Gereau, R. W. 4th Segmental hyperalgesia to mechanical stimulus in interstitial cystitis\/bladder pain syndrome: evidence of central sensitization. J. Urol. 191, 1294\u20131299 (2014).","journal-title":"J. Urol."},{"key":"1044_CR78","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3949\/ccjm.90a.22019","volume":"90","author":"MM Volcheck","year":"2023","unstructured":"Volcheck, M. M., Graham, S. M., Fleming, K. C., Mohabbat, A. B. & Luedtke, C. A. Central sensitization, chronic pain, and other symptoms: better understanding, better management. Cleve. Clin. J. Med. 90, 245\u2013254 (2023).","journal-title":"Cleve. Clin. J. Med."},{"key":"1044_CR79","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/iju.13970","volume":"26","author":"Y Homma","year":"2019","unstructured":"Homma, Y. Interstitial cystitis, bladder pain syndrome, hypersensitive bladder, and interstitial cystitis\/bladder pain syndrome \u2014 clarification of definitions and relationships. Int. J. Urol. 26, 20\u201324 (2019).","journal-title":"Int. J. Urol."},{"key":"1044_CR80","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.juro.2015.05.105","volume":"194","author":"HH Lai","year":"2015","unstructured":"Lai, H. H. et al. Painful bladder filling and painful urgency are distinct characteristics in men and women with urological chronic pelvic pain syndromes: a MAPP Research Network Study. J. Urol. 194, 1634\u20131641 (2015).","journal-title":"J. Urol."},{"key":"1044_CR81","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/iju.12308","volume":"21","author":"N Yoshimura","year":"2014","unstructured":"Yoshimura, N. et al. Bladder afferent hyperexcitability in bladder pain syndrome\/interstitial cystitis. Int. J. Urol. 21, 18\u201325 (2014).","journal-title":"Int. J. Urol."},{"key":"1044_CR82","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1113\/JP272148","volume":"594","author":"EJ Gonzalez","year":"2016","unstructured":"Gonzalez, E. J., Heppner, T. J., Nelson, M. T. & Vizzard, M. A. Purinergic signalling underlies transforming growth factor-\u03b2-mediated bladder afferent nerve hyperexcitability. J. Physiol. 594, 3575\u20133588 (2016).","journal-title":"J. Physiol."},{"key":"1044_CR83","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41585-018-0135-5","volume":"16","author":"JQ Clemens","year":"2019","unstructured":"Clemens, J. Q. et al. Urologic chronic pelvic pain syndrome: insights from the MAPP research network. Nat. Rev. Urol. 16, 187\u2013200 (2019).","journal-title":"Nat. Rev. Urol."},{"key":"1044_CR84","doi-asserted-by":"publisher","first-page":"F298","DOI":"10.1152\/ajprenal.00435.2019","volume":"318","author":"L Grundy","year":"2020","unstructured":"Grundy, L. et al. Histamine induces peripheral and central hypersensitivity to bladder distension via the histamine H1 receptor and TRPV1. Am. J. Physiol. Ren. Physiol. 318, F298\u2013F314 (2020).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1044_CR85","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/ijms24010820","volume":"24","author":"YH Jiang","year":"2023","unstructured":"Jiang, Y. H., Jhang, J. F., Birder, L. A. & Kuo, H. C. Sensory receptor, inflammatory, and apoptotic protein expression in the bladder urothelium of patients with different subtypes of interstitial cystitis\/bladder pain syndrome. Int. J. Mol. Sci. 24, 820 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1044_CR86","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/JU.0000000000002278","volume":"207","author":"Y Akiyama","year":"2022","unstructured":"Akiyama, Y. et al. Overexpression of HIF1\u03b1 in Hunner lesions of interstitial cystitis: pathophysiological implications. J. Urol. 207, 635\u2013646 (2022).","journal-title":"J. Urol."},{"key":"1044_CR87","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/iju.12402","volume":"21","author":"JD Lee","year":"2014","unstructured":"Lee, J. D. & Lee, M. H. Metallothionein overexpression of bladder biopsies associated with tissue hypoxia in patients with interstitial cystitis\/painful bladder syndrome. Int. J. Urol. 21, 719\u2013723 (2014).","journal-title":"Int. J. Urol."},{"key":"1044_CR88","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.juro.2018.03.133","volume":"200","author":"JF Jhang","year":"2018","unstructured":"Jhang, J. F. et al. Epstein\u2013Barr virus as a potential etiology of persistent bladder inflammation in human interstitial cystitis\/bladder pain syndrome. J. Urol. 200, 590\u2013596 (2018). In this study, EBV infection is present in 87.5% and 17.4% of bladder specimens from patients, respectively, with and without IC\/BPS and Hunner lesions. Bladder EBV infection in T cells might be linked to the pathogenesis of persistent inflammation in IC\/BPS.","journal-title":"J. Urol."},{"key":"1044_CR89","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s00345-025-05451-5","volume":"43","author":"WR Yu","year":"2025","unstructured":"Yu, W. R., Jiang, Y. H., Jhang, J. F. & Kuo, H. C. Focal or diffuse bladder wall thickness on bladder computed tomography indicates more severe bladder wall inflammation in patients with interstitial cystitis. World J. Urol. 43, 100 (2025).","journal-title":"World J. Urol."},{"key":"1044_CR90","doi-asserted-by":"publisher","first-page":"865463","DOI":"10.1155\/2014\/865463","volume":"2014","author":"SK Keay","year":"2014","unstructured":"Keay, S. K., Birder, L. A. & Chai, T. C. Evidence for bladder urothelial pathophysiology in functional bladder disorders. Biomed. Res. Int. 2014, 865463 (2014).","journal-title":"Biomed. Res. Int."},{"key":"1044_CR91","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.eururo.2020.01.002","volume":"77","author":"KJ Ko","year":"2020","unstructured":"Ko, K. J. et al. Comparison of the efficacy between transurethral coagulation and transurethral resection of Hunner lesion in interstitial cystitis\/bladder pain syndrome patients: a prospective randomized controlled trial. Eur. Urol. 77, 644\u2013651 (2020).","journal-title":"Eur. Urol."},{"key":"1044_CR92","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1007\/s00345-022-04062-8","volume":"40","author":"HS Son","year":"2022","unstructured":"Son, H. S., Yoon, H., Lee, H. S. & Kim, J. H. Prospective randomized controlled trial comparing fulguration versus fulguration and hydrodistension for Hunner-type interstitial cystitis\/bladder pain syndrome. World J. Urol. 40, 2071\u20132076 (2022).","journal-title":"World J. Urol."},{"key":"1044_CR93","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/nau.24726","volume":"40","author":"J Natarajan","year":"2021","unstructured":"Natarajan, J. et al. Pain and functionality improved when underlying neuromuscular dysfunction addressed in chronic pelvic pain patients. Neurourol. Urodyn. 40, 1609\u20131615 (2021).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR94","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/JU.0000000000000250","volume":"202","author":"HH Lai","year":"2019","unstructured":"Lai, H. H., Thu, J. H. L., Moh, F. V., Paradis, A. & Vetter, J. Clustering of patients with interstitial cystitis\/bladder pain syndrome and chronic prostatitis\/chronic pelvic pain syndrome. J. Urol. 202, 546\u2013551 (2019).","journal-title":"J. Urol."},{"key":"1044_CR95","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00192-021-04761-7","volume":"33","author":"Y Abe-Takahashi","year":"2022","unstructured":"Abe-Takahashi, Y. et al. Examination of pelvic floor muscle elasticity in patients with interstitial cystitis\/bladder pain syndrome using real-time tissue elastography. Int. Urogynecol. J. 33, 619\u2013626 (2022).","journal-title":"Int. Urogynecol. J."},{"key":"1044_CR96","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.sxmr.2021.03.002","volume":"10","author":"DA van Reijn-Baggen","year":"2022","unstructured":"van Reijn-Baggen, D. A. et al. Pelvic floor physical therapy for pelvic floor hypertonicity: a systematic review of treatment efficacy. Sex. Med. Rev. 10, 209\u2013230 (2022).","journal-title":"Sex. Med. Rev."},{"key":"1044_CR97","first-page":"E1315","volume":"25","author":"WR Yu","year":"2022","unstructured":"Yu, W. R., Chuang, F. C., Chang, W. C. & Kuo, H. C. Pelvic floor myofascial pain might influence treatment outcome of interstitial cystitis\/bladder pain syndrome: a prospective study. Pain Physician 25, E1315\u2013E1322 (2022).","journal-title":"Pain Physician"},{"key":"1044_CR98","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1097\/SPV.0000000000001374","volume":"29","author":"JA Greer","year":"2023","unstructured":"Greer, J. A., Heye, K. R., McGlynn, A., Johansson, S. & Vaccaro, C. M. Association of pelvic floor disorders, perceived psychological stress, and military service in U.S. navy servicewomen: a cross-sectional survey. Urogynecology 29, 966\u2013973 (2023).","journal-title":"Urogynecology"},{"key":"1044_CR99","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/JU.0000000000002679","volume":"208","author":"P Gupta","year":"2022","unstructured":"Gupta, P. et al. Is pelvic floor muscle tenderness a distinct urologic chronic pelvic pain syndrome phenotype? Findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Symptom Pattern Study. J. Urol. 208, 341\u2013349 (2022).","journal-title":"J. Urol."},{"key":"1044_CR100","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1007\/s11255-022-03294-2","volume":"54","author":"WR Yu","year":"2022","unstructured":"Yu, W. R., Chang, W. C. & Kuo, H. C. Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms. Int. Urol. Nephrol. 54, 2157\u20132165 (2022).","journal-title":"Int. Urol. Nephrol."},{"key":"1044_CR101","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11255-014-0908-6","volume":"47","author":"YC Chuang","year":"2015","unstructured":"Chuang, Y. C., Weng, S. F., Hsu, Y. W., Huang, C. L. C. & Wu, M. P. Increased risks of healthcare-seeking behaviors of anxiety, depression and insomnia among patients with bladder pain syndrome\/interstitial cystitis: a nationwide population-based study. Int. Urol. Nephrol. 47, 275\u2013281 (2015).","journal-title":"Int. Urol. Nephrol."},{"key":"1044_CR102","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/nau.24019","volume":"38","author":"WR Yu","year":"2019","unstructured":"Yu, W. R., Peng, T. C., Yeh, H. L. & Kuo, H. C. Anxiety severity does not influence treatment outcomes in patients with interstitial cystitis\/bladder pain syndrome. Neurourol. Urodyn. 38, 1602\u20131610 (2019).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR103","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/nau.23421","volume":"37","author":"LC McKernan","year":"2018","unstructured":"McKernan, L. C. et al. Psychosocial co-morbidities in interstitial cystitis\/bladder pain syndrome (IC\/BPS): a systematic review. Neurourol. Urodyn. 37, 926\u2013941 (2018). This article is a systematic review of the effect of psychosocial factors on IC\/BPS, of the comorbid anxiety, depression and QOL issues that might increase IC\/BPS symptoms, and of the self-management interventions that might be helpful.","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR104","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/j.1464-410X.2010.09237.x","volume":"106","author":"W Boucher","year":"2010","unstructured":"Boucher, W., Kempuraj, D., Michaelian, M. & Theoharides, T. C. Corticotropin-releasing hormone-receptor 2 is required for acute stress-induced bladder vascular permeability and release of vascular endothelial growth factor. BJU Int. 106, 1394\u20131399 (2010).","journal-title":"BJU Int."},{"key":"1044_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55584-y","volume":"9","author":"JF Jhang","year":"2019","unstructured":"Jhang, J. F. et al. Dysregulation of bladder corticotropin-releasing hormone receptor in the pathogenesis of human interstitial cystitis\/bladder pain syndrome. Sci. Rep. 9, 19169 (2019).","journal-title":"Sci. Rep."},{"key":"1044_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039935","volume":"7","author":"EL Overman","year":"2012","unstructured":"Overman, E. L., Rivier, J. E. & Moeser, A. J. CRF induces intestinal epithelial barrier injury via the release of mast cell proteases and TNF-\u03b1. PLoS ONE 7, e39935 (2012).","journal-title":"PLoS ONE"},{"key":"1044_CR107","doi-asserted-by":"publisher","DOI":"10.1111\/luts.12508","volume":"16","author":"WR Yu","year":"2024","unstructured":"Yu, W. R. & Kuo, H. C. Multimodal therapies and strategies for the treatment of interstitial cystitis\/bladder pain syndrome in Taiwan. Low. Urin. Tract Symptoms 16, e12508 (2024).","journal-title":"Low. Urin. Tract Symptoms"},{"key":"1044_CR108","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00192-024-05793-5","volume":"35","author":"S Knox","year":"2024","unstructured":"Knox, S., Offiah, I. & Hashim, H. Evaluation of central sensitisation in bladder pain syndrome: a systematic review. Int. Urogynecol. J. 35, 1109\u20131118 (2024).\u00a0","journal-title":"Int. Urogynecol. J."},{"key":"1044_CR109","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/ajo.13596","volume":"62","author":"A Ryan","year":"2022","unstructured":"Ryan, A., Healey, M., Cheng, C., Dior, U. & Reddington, C. Central sensitisation in pelvic pain: a Cohort Study. Aust. N. Z. J. Obstet. Gynaecol. 62, 868\u2013874 (2022).","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"1044_CR110","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/JU.0000000000003820","volume":"211","author":"ES Barker","year":"2024","unstructured":"Barker, E. S. et al. Urologic chronic pelvic pain syndrome flares: a comprehensive, systematic review and meta-analysis of the peer-reviewed flare literature. J. Urol. 211, 341\u2013353 (2024).","journal-title":"J. Urol."},{"key":"1044_CR111","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/JU.0000000000003155","volume":"209","author":"S Sutcliffe","year":"2023","unstructured":"Sutcliffe, S. et al. Associations between urological chronic pelvic pain syndrome symptom flares, illness impact, and health care seeking activity: findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Symptom Patterns Study. J. Urol. 209, 719\u2013725 (2023).","journal-title":"J. Urol."},{"key":"1044_CR112","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1111\/1471-0528.17915","volume":"131","author":"L Coxon","year":"2024","unstructured":"Coxon, L. et al. Symptom flares in women with chronic pelvic pain: questionnaire study within a cohort study (translational research in pelvic pain (TRiPP)). BJOG 131, 1832\u20131840 (2024).","journal-title":"BJOG"},{"key":"1044_CR113","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/SPV.0000000000001536","volume":"30","author":"R Ritts","year":"2024","unstructured":"Ritts, R. et al. Symptomatic autonomic dysfunction in interstitial cystitis\/bladder pain syndrome. Urogynecology 30, 821\u2013828 (2024).","journal-title":"Urogynecology"},{"key":"1044_CR114","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/nau.25115","volume":"42","author":"EK Kim","year":"2023","unstructured":"Kim, E. K. et al. Development of a patient-centered text message-based platform for the self-management of interstitial cystitis\/bladder pain syndrome symptoms. Neurourol. Urodyn. 42, 510\u2013522 (2023).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR115","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.3390\/jcm11206221","volume":"11","author":"WR Yu","year":"2022","unstructured":"Yu, W. R. et al. Multimodal treatment with cognitive behavioral therapeutic intervention plus bladder treatment is more effective than monotherapy for patients with interstitial cystitis\/bladder pain syndrome \u2014 a randomized clinical trial. J. Clin. Med. 11, 6221 (2022).","journal-title":"J. Clin. Med."},{"key":"1044_CR116","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/JU.0000000000003847","volume":"211","author":"JM Lackner","year":"2024","unstructured":"Lackner, J. M. et al. Cognitive behavioral therapy for chronic pelvic pain: what is it and does it work? J. Urol. 211, 539\u2013550 (2024).","journal-title":"J. Urol."},{"key":"1044_CR117","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1007\/s00345-020-03099-x","volume":"38","author":"S Y\u0131ld\u0131r\u0131m","year":"2020","unstructured":"Y\u0131ld\u0131r\u0131m, S., Shoskes, D., Kulkarni, S. & Laguna, P. Urinary microbiome in uncomplicated and interstitial cystitis: is there any similarity? World J. Urol. 38, 2721\u20132731 (2020).","journal-title":"World J. Urol."},{"key":"1044_CR118","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.urology.2007.12.091","volume":"71","author":"JW Warren","year":"2008","unstructured":"Warren, J. W. et al. Urinary tract infection and inflammation at onset of interstitial cystitis\/painful bladder syndrome. Urology 71, 1085\u20131090 (2008).","journal-title":"Urology"},{"key":"1044_CR119","first-page":"259","volume":"18","author":"A Javan Balegh Marand","year":"2021","unstructured":"Javan Balegh Marand, A. et al. Urinary microbiome and its correlation with disorders of the genitourinary system. Urol. J. 18, 259\u2013270 (2021).","journal-title":"Urol. J."},{"key":"1044_CR120","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/bju.16439","volume":"134","author":"C Fu","year":"2024","unstructured":"Fu, C. et al. The microbiota in patients with interstitial cystitis\/bladder pain syndrome: a systematic review. BJU Int. 134, 869\u2013880 (2024).","journal-title":"BJU Int."},{"key":"1044_CR121","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.euf.2025.01.008","volume":"10","author":"D Nandwana","year":"2025","unstructured":"Nandwana, D., Zhang, Y. & Feng, N. Contribution of the microbiome to interstitial cystitis\/bladder pain syndrome: a mini review. Eur. Urol. Focus 10, 893\u2013897 (2025). This article is a review of the possible pathophysiology of altered microbiome and IC\/BPS, including urinary, vaginal and gastrointestinal microbiota, and their interactions with host inflammatory and metabolic pathways.","journal-title":"Eur. Urol. Focus"},{"key":"1044_CR122","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/JU.0000000000003189","volume":"209","author":"AJ Wolfe","year":"2023","unstructured":"Wolfe, A. J. et al. Detection of bacteria in bladder mucosa of adult females. J. Urol. 209, 937\u2013949 (2023).","journal-title":"J. Urol."},{"key":"1044_CR123","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.urology.2016.02.043","volume":"92","author":"DA Shoskes","year":"2016","unstructured":"Shoskes, D. A. et al. The urinary microbiome differs significantly between patients with chronic prostatitis\/chronic pelvic pain syndrome and controls as well as between patients with different clinical phenotypes. Urology 92, 26\u201332 (2016).","journal-title":"Urology"},{"key":"1044_CR124","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/nau.25550","volume":"43","author":"N Hashemi","year":"2024","unstructured":"Hashemi, N. et al. A systematic and comprehensive review of the role of microbiota in urinary chronic pelvic pain syndrome. Neurourol. Urodyn. 43, 1859\u20131882 (2024).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR125","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/nau.23006","volume":"36","author":"MJ Drake","year":"2017","unstructured":"Drake, M. J., Morris, N., Apostolidis, A., Rahnama\u2019I, M. S. & Marchesi, J. R. The urinary microbiome and its contribution to lower urinary tract symptoms; ICI-RS 2015. Neurourol. Urodyn. 36, 850\u2013853 (2017).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR126","doi-asserted-by":"publisher","first-page":"101743","DOI":"10.1016\/j.cont.2024.101743","volume":"14","author":"PO Elferink","year":"2025","unstructured":"Elferink, P. O. et al. Microbiome profiling in patients with bladder pain syndrome\/interstitial cystitis. Continence 14, 101743 (2025).","journal-title":"Continence"},{"key":"1044_CR127","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s11262-020-01767-z","volume":"56","author":"MTS Robles","year":"2020","unstructured":"Robles, M. T. S. et al. Analysis of viruses present in urine from patients with interstitial cystitis. Virus Genes\u00a056, 430\u2013438 (2020).","journal-title":"Virus Genes"},{"key":"1044_CR128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137310","volume":"10","author":"BJ Winter","year":"2015","unstructured":"Winter, B. J., O\u2019Connell, H. E., Bowden, S., Carey, M. & Eisen, D. P. A case control study reveals that polyomaviruria is significantly associated with interstitial cystitis and vesical ulceration. PLoS ONE 10, e0137310 (2015).","journal-title":"PLoS ONE"},{"key":"1044_CR129","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1080\/14656566.2018.1505865","volume":"19","author":"AE Dellis","year":"2018","unstructured":"Dellis, A. E. & Papatsoris, A. G. Bridging pharmacotherapy and minimally invasive surgery in interstitial cystitis\/bladder pain syndrome treatment. Expert Opin. Pharmacother. 19, 1369\u20131373 (2018).","journal-title":"Expert Opin. Pharmacother."},{"key":"1044_CR130","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/iju.12350","volume":"21","author":"M Kajiwara","year":"2014","unstructured":"Kajiwara, M. et al. Therapeutic efficacy of narrow band imaging-assisted transurethral electrocoagulation for ulcer-type interstitial cystitis\/painful bladder syndrome. Int. J. Urol. 21, 57\u201360 (2014).","journal-title":"Int. J. Urol."},{"key":"1044_CR131","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/luts.12343","volume":"13","author":"A Neale","year":"2021","unstructured":"Neale, A., Malik, N., Taylor, C., Sahai, A. & Malde, S. Bladder pain syndrome\/interstitial cystitis in contemporary UK practice: outcomes of phenotype-directed management. Low. Urin. Tract Symptoms 13, 123\u2013128 (2021).","journal-title":"Low. Urin. Tract Symptoms"},{"key":"1044_CR132","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/nau.22837","volume":"35","author":"A Niimi","year":"2016","unstructured":"Niimi, A. et al. Hydrodistension with or without fulguration of hunner lesions for interstitial cystitis: long-term outcomes and prognostic predictors. Neurourol. Urodyn. 35, 965\u2013969 (2016).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR133","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00192-016-3213-3","volume":"28","author":"L Mateu","year":"2017","unstructured":"Mateu, L. et al. Pain relief after triamcinolone infiltration in patients with bladder pain syndrome with Hunner\u2019s ulcers. Int. Urogynecol. J. 28, 1027\u20131031 (2017).","journal-title":"Int. Urogynecol. J."},{"key":"1044_CR134","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.5213\/inj.2142100.050","volume":"26","author":"JF Jhang","year":"2022","unstructured":"Jhang, J. F. et al. Improved urothelial cell proliferation, cytoskeleton and barrier function protein expression in the patients with interstitial cystitis\/bladder pain syndrome after intravesical platelet-rich plasma injection. Int. Neurourol. J. 26, S57\u2013S67 (2022).","journal-title":"Int. Neurourol. J."},{"key":"1044_CR135","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/iju.12320","volume":"21","author":"HJ Kim","year":"2014","unstructured":"Kim, H. J. et al. Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome\/interstitial cystitis with Hunner\u2019s lesion. Int. J. Urol. 21, 69\u201373 (2014).","journal-title":"Int. J. Urol."},{"key":"1044_CR136","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00192-022-05110-y","volume":"33","author":"F Queissert","year":"2022","unstructured":"Queissert, F., Bruecher, B., van Ophoven, A. & Schrader, A. J. Supratrigonal cystectomy and augmentation cystoplasty with ileum or ileocecum in the treatment of ulcerative interstitial cystitis\/bladder pain syndrome: a 14-year follow-up. Int. Urogynecol. J. 33, 1267\u20131272 (2022).","journal-title":"Int. Urogynecol. J."},{"key":"1044_CR137","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/nau.23339","volume":"37","author":"SY Wu","year":"2018","unstructured":"Wu, S. Y. & Kuo, H. C. A real-world experience with augmentation enterocystoplasty \u2014 high patient satisfaction with high complication rates. Neurourol. Urodyn. 37, 744\u2013750 (2018).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR138","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s11934-006-0051-8","volume":"7","author":"E Graham","year":"2006","unstructured":"Graham, E. & Chai, T. C. Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis. Curr. Urol. Rep. 7, 440\u2013446 (2006).","journal-title":"Curr. Urol. Rep."},{"key":"1044_CR139","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00192-020-04517-9","volume":"32","author":"R Taneja","year":"2021","unstructured":"Taneja, R. Current status of oral pentosan polysulphate in bladder pain syndrome\/interstitial cystitis. Int. Urogynecol. J. 32, 1107\u20131115 (2021).","journal-title":"Int. Urogynecol. J."},{"key":"1044_CR140","doi-asserted-by":"publisher","DOI":"10.1177\/17562872221102809","author":"B Grigoryan","year":"2022","unstructured":"Grigoryan, B., Kasyan, G., Pivazyan, L. & Pushkar, D. Pentosan polysulfate in patients with bladder pain syndrome\/interstitial cystitis with Hunner\u2019s lesions or glomerulations: systematic review and meta-analysis. Ther. Adv. Urol., https:\/\/doi.org\/10.1177\/17562872221102809 (2022).","journal-title":"Ther. Adv. Urol."},{"key":"1044_CR141","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1159\/000447863","volume":"39","author":"JS Pyo","year":"2016","unstructured":"Pyo, J. S. & Cho, W. J. Systematic review and meta-analysis of intravesical hyaluronic acid and hyaluronic acid\/chondroitin sulfate instillation for interstitial cystitis\/painful bladder syndrome. Cell. Physiol. Biochem. 39, 1618\u20131625 (2016).","journal-title":"Cell. Physiol. Biochem."},{"key":"1044_CR142","doi-asserted-by":"publisher","first-page":"484.e7","DOI":"10.1016\/j.urology.2011.09.049","volume":"79","author":"JH Shie","year":"2012","unstructured":"Shie, J. H., Liu, H. T. & Kuo, H. C. Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis\/painful bladder syndrome. Urology 79, 484.e7\u2013484.e13 (2012).","journal-title":"Urology"},{"key":"1044_CR143","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11934-013-0369-y","volume":"14","author":"MA Colaco","year":"2013","unstructured":"Colaco, M. A. & Evans, R. J. Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis\/bladder pain syndrome. Curr. Urol. Rep. 14, 442\u2013447 (2013).","journal-title":"Curr. Urol. Rep."},{"key":"1044_CR144","first-page":"7739","volume":"22","author":"CL Parsons","year":"2015","unstructured":"Parsons, C. L., Koziol, J. A., Proctor, J. G., Zupkas, P. & Argade, S. Heparin and alkalinized lidocaine versus alkalinized lidocaine for treatment of interstitial cystitis symptoms. Can. J. Urol. 22, 7739\u20137744 (2015).","journal-title":"Can. J. Urol."},{"key":"1044_CR145","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/nau.25142","volume":"42","author":"NP Moss","year":"2023","unstructured":"Moss, N. P. et al. A prospective, randomized trial comparing intravesical dimethyl sulfoxide (DMSO) to bupivacaine, triamcinolone, and heparin (BTH), for newly diagnosed interstitial cystitis\/painful bladder syndrome (IC\/PBS). Neurourol. Urodyn. 42, 615\u2013622 (2023).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR146","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bj.2021.06.006","volume":"4","author":"HJ Wang","year":"2022","unstructured":"Wang, H. J. et al. Low energy shock wave therapy attenuates mitochondrial dysfunction and improves bladder function in HCl induced cystitis in rats. Biomed. J. 4, 482\u2013490 (2022).","journal-title":"Biomed. J."},{"key":"1044_CR147","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/nau.25027","volume":"42","author":"LS Jhang","year":"2023","unstructured":"Jhang, L. S. et al. Use of low-intensity extracorporeal shock wave therapy in the management of interstitial cystitis\/bladder pain syndrome patients: a thirty case study in a tertiary medical center. Neurourol. Urodyn. 42, 65\u201372 (2023).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR148","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/biomedicines10020396","volume":"10","author":"YH Jiang","year":"2022","unstructured":"Jiang, Y. H., Jhang, J. F., Lee, Y. K. & Kuo, H. C. Low-energy shock wave plus intravesical instillation of botulinum toxin A for interstitial cystitis\/bladder pain syndrome: pathophysiology and preliminary result of a novel minimally invasive treatment. Biomedicines 10, 396 (2022).","journal-title":"Biomedicines"},{"key":"1044_CR149","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00281-018-0674-0","volume":"40","author":"LA Birder","year":"2018","unstructured":"Birder, L. A. & Kullmann, F. A. Role of neurogenic inflammation in local communication in the visceral mucosa. Semin. Immunopathol. 40, 261\u2013279 (2018).","journal-title":"Semin. Immunopathol."},{"key":"1044_CR150","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1046\/j.1464-410X.1997.00097.x","volume":"79","author":"EM Lowe","year":"1997","unstructured":"Lowe, E. M. et al. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br. J. Urol. 79, 572\u2013577 (1997).","journal-title":"Br. J. Urol."},{"key":"1044_CR151","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.urology.2007.04.038","volume":"70","author":"HT Liu","year":"2007","unstructured":"Liu, H. T. & Kuo, H. C. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 70, 463\u2013468 (2007).","journal-title":"Urology"},{"key":"1044_CR152","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/diagnostics12010075","volume":"12","author":"HY Lin","year":"2021","unstructured":"Lin, H. Y. et al. Urinary biomarkers in interstitial cystitis\/bladder pain syndrome and its impact on therapeutic outcome. Diagnostics 12, 75 (2021).","journal-title":"Diagnostics"},{"key":"1044_CR153","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/tcmj.tcmj_313_21","volume":"35","author":"YH Jiang","year":"2023","unstructured":"Jiang, Y. H., Jhang, J. F. & Kuo, H. C. The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis. Tzu Chi Med. J. 35, 31\u201337 (2023).","journal-title":"Tzu Chi Med. J."},{"key":"1044_CR154","doi-asserted-by":"publisher","first-page":"853776","DOI":"10.3389\/fphar.2022.853776","volume":"13","author":"YH Jiang","year":"2022","unstructured":"Jiang, Y. H. et al. Therapeutic efficacy of intravesical platelet-rich plasma injections for interstitial cystitis\/bladder pain syndrome \u2014 a comparative sudy of different injection number, additives and concentrations. Front. Pharmacol. 13, 853776 (2022).","journal-title":"Front. Pharmacol."},{"key":"1044_CR155","doi-asserted-by":"publisher","first-page":"755615","DOI":"10.3389\/fphar.2021.755615","volume":"12","author":"CL Chen","year":"2021","unstructured":"Chen, C. L. et al. A novel intravesical dextrose injection improves lower urinary tract symptoms on interstitial cystitis\/bladder pain syndrome. Front. Pharmacol. 12, 755615 (2021).","journal-title":"Front. Pharmacol."},{"key":"1044_CR156","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5152\/tud.2023.22243","volume":"49","author":"MS Rahnama\u2019I","year":"2023","unstructured":"Rahnama\u2019I, M. S., Salehi-Pourmehr, H., Saeedi, S., Tayebi, S. & Hajebrahimi, S. Intravesical injection of abobotulinumtoxin-A in patients with bladder pain syndrome\/interstitial cystitis. Urol. Res. Pract. 49, 205\u2013210 (2023).","journal-title":"Urol. Res. Pract."},{"key":"1044_CR157","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/toxins15020121","volume":"15","author":"JF Jhang","year":"2023","unstructured":"Jhang, J. F., Yu, W. R. & Kuo, H. C. Comparison of the clinical efficacy and adverse events between intravesical injections of platelet-rich plasma and botulinum toxin A for the treatment of interstitial cystitis refractory to conventional treatment. Toxins 15, 121 (2023).","journal-title":"Toxins"},{"key":"1044_CR158","doi-asserted-by":"publisher","first-page":"601653","DOI":"10.1155\/2014\/601653","volume":"2014","author":"P Tyagi","year":"2014","unstructured":"Tyagi, P. et al. Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis\/painful bladder syndrome. ISRN Pharmacol. 2014, 601653 (2014).","journal-title":"ISRN Pharmacol."},{"key":"1044_CR159","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.juro.2015.12.090","volume":"195","author":"N Kawamorita","year":"2016","unstructured":"Kawamorita, N. et al. Liposome based intravesical therapy targeting nerve growth factor ameliorates bladder hypersensitivity in rats with experimental colitis. J. Urol. 195, 1920\u20131926 (2016).","journal-title":"J. Urol."},{"key":"1044_CR160","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1002\/nau.25547","volume":"43","author":"ZG Cao","year":"2024","unstructured":"Cao, Z. G., Li, F. D., Zhang, C. L., Luo, G. X. & Chang, D. H. The efficacy and safety of monoclonal antibody therapies for interstitial cystitis\/bladder pain syndrome: a meta-analysis of randomized controlled trials. Neurourol. Urodyn. 43, 1903\u20131909 (2024).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR161","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-016-0193-z","volume":"17","author":"H Wang","year":"2017","unstructured":"Wang, H., Russell, L. J., Kelly, K. M., Wang, S. & Thipphawong, J. Fulranumab in patients with interstitial cystitis\/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study. BMC Urol. 17, 2 (2017).","journal-title":"BMC Urol."},{"key":"1044_CR162","doi-asserted-by":"publisher","first-page":"e2024.00009","DOI":"10.4293\/JSLS.2024.00009","volume":"28","author":"LSR Rog\u00e9rio","year":"2024","unstructured":"Rog\u00e9rio, L. S. R. et al. A pain desensitization algorithm for phenotyping and treating chronic pelvic pain. JSLS 28, e2024.00009 (2024).","journal-title":"JSLS"},{"key":"1044_CR163","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/01.ju.0000083020.06212.3d","volume":"170","author":"GR Sant","year":"2003","unstructured":"Sant, G. R. et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J. Urol. 170, 810\u2013815 (2003).","journal-title":"J. Urol."},{"key":"1044_CR164","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0022-5347(01)66137-8","volume":"155","author":"T Forsell","year":"1996","unstructured":"Forsell, T., Ruutu, M., Isoniemi, H., Ahonen, J. & Alfthan, O. Cyclosporine in severe interstitial cystitis. J. Urol. 155, 1591\u20131593 (1996).","journal-title":"J. Urol."},{"key":"1044_CR165","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1097\/01.ju.0000181808.45786.84","volume":"174","author":"J Sairanen","year":"2005","unstructured":"Sairanen, J. et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J. Urol. 174, 2235\u20132238 (2005).","journal-title":"J. Urol."},{"key":"1044_CR166","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/iju.13978","volume":"26","author":"NN Mishra","year":"2019","unstructured":"Mishra, N. N., Riedl, C., Shah, S. & Pathak, N. Intravesical tacrolimus in treatment of intractable interstitial cystitis\/bladder pain syndrome \u2014 a pilot study. Int. J. Urol. 26, 68\u201372 (2019).","journal-title":"Int. J. Urol."},{"key":"1044_CR167","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","volume":"22","author":"DI Jang","year":"2021","unstructured":"Jang, D. I. et al. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int. J. Mol. Sci. 22, 2719 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1044_CR168","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.juro.2013.06.038","volume":"191","author":"PC Bosch","year":"2014","unstructured":"Bosch, P. C. A randomized, double-blind, placebo-controlled trial of adalimumab for interstitial cystitis\/bladder pain syndrome. J. Urol. 191, 77\u201382 (2014).","journal-title":"J. Urol."},{"key":"1044_CR169","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.eururo.2018.07.026","volume":"74","author":"PC Bosch","year":"2018","unstructured":"Bosch, P. C. A randomized, double-blind, placebo-controlled trial of certolizumab pegol in women with refractory interstitial cystitis\/bladder pain syndrome. Eur. Urol. 74, 623\u2013630 (2018).","journal-title":"Eur. Urol."},{"key":"1044_CR170","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5213\/inj.2012.16.4.175","volume":"16","author":"HJ Jeong","year":"2012","unstructured":"Jeong, H. J. Effects of a short course of oral prednisolone in patients with bladder pain syndrome with fluctuating, worsening pain despite low-dose triple therapy. Int. Neurourol. J. 16, 175\u2013180 (2012).","journal-title":"Int. Neurourol. J."},{"key":"1044_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euros.2023.07.006","volume":"56","author":"Y Akiyama","year":"2023","unstructured":"Akiyama, Y. et al. Efficacy and safety of low-dose oral prednisolone for patients with refractory hunner-type interstitial cystitis. Eur. Urol. Open Sci. 56, 1\u20138 (2023).","journal-title":"Eur. Urol. Open Sci."},{"key":"1044_CR172","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.4880","volume":"7","author":"SH Shen","year":"2024","unstructured":"Shen, S. H. et al. Intravesical interferon therapy vs hyaluronic acid for pain among female individuals with interstitial cystitis: a randomized clinical trial. JAMA Netw. Open\u00a07, e244880 (2024).\u00a0","journal-title":"JAMA Netw. Open"},{"key":"1044_CR173","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/biomedicines12030522","volume":"12","author":"HC Kuo","year":"2024","unstructured":"Kuo, H. C., Peng, C. W., Jiang, Y. H. & Jhang, J. F. Urinary viral spectrum in patients with interstitial cystitis\/bladder pain syndrome and the clinical efficacy of valacyclovir treatment. Biomedicines 12, 522 (2024).","journal-title":"Biomedicines"},{"key":"1044_CR174","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/2053369120936426","volume":"26","author":"A Bhide","year":"2020","unstructured":"Bhide, A., Tailor, V. & Khulla, R. V. Interstitial cystitis\/bladder pain syndrome and recurrent urinary tract infection and the potential role of the urinary microbiome. Post. Reprod. Health 26, 87\u201390 (2020).","journal-title":"Post. Reprod. Health"},{"key":"1044_CR175","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/nau.24840","volume":"41","author":"K Garba","year":"2022","unstructured":"Garba, K. et al. Real world use of oral treatments in interstitial cystitis\/bladder pain syndrome in the UK: outcome of a cross sectional study. Neurourol. Urodyn. 41, 416\u2013422 (2022).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR176","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.juro.2015.09.075","volume":"195","author":"JC Nickel","year":"2016","unstructured":"Nickel, J. C. et al. Assessment of the lower urinary tract microbiota during symptom flare in women with urologic chronic pelvic pain syndrome: a MAPP Network Study. J. Urol. 195, 356\u2013362 (2016).","journal-title":"J. Urol."},{"key":"1044_CR177","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/ijms25010163","volume":"25","author":"JF Jhang","year":"2023","unstructured":"Jhang, J. F., Jiang, Y. H., Lin, T. Y. & Kuo, H. C. The tumor necrosis factor-\u03b1 level in platelet-rich plasma might be associated with treatment outcome in patients with interstitial cystitis\/bladder pain sndrome or recurrent urinary tract infection. Int. J. Mol. Sci. 25, 163 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1044_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98504-9","volume":"11","author":"T Saito","year":"2021","unstructured":"Saito, T. et al. Functional and histologic imaging of urinary bladder wall after exposure to psychological stress and protamine sulfate. Sci. Rep. 11, 19440 (2021).","journal-title":"Sci. Rep."},{"key":"1044_CR179","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/nau.24771","volume":"40","author":"AJ Soriano","year":"2021","unstructured":"Soriano, A. J. et al. Pilot randomized controlled trial of a hypnosis intervention for women with bladder pain syndrome. Neurourol. Urodyn. 40, 1945\u20131954 (2021).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR180","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00192-021-04812-z","volume":"33","author":"A Shatkin-Margolis","year":"2022","unstructured":"Shatkin-Margolis, A. et al. The effect of mindfulness-based stress reduction on the urinary microbiome in interstitial cystitis. Int. Urogynecol. J. 33, 665\u2013671 (2022).","journal-title":"Int. Urogynecol. J."},{"key":"1044_CR181","first-page":"4","volume":"34","author":"S Khandwala","year":"2020","unstructured":"Khandwala, S. & Cruff, J. The role of yoga in the management of bladder pain syndrome: a single-arm pilot study. Adv. Mind Body Med. 34, 4\u20139 (2020).","journal-title":"Adv. Mind Body Med."},{"key":"1044_CR182","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3390\/jcm10040862","volume":"10","author":"PS Borrego-Jimenez","year":"2021","unstructured":"Borrego-Jimenez, P. S. et al. Improvement in quality of life with pelvic floor muscle training and biofeedback in patients with painful bladder syndrome\/interstitial cystitis. J. Clin. Med. 10, 862 (2021).","journal-title":"J. Clin. Med."},{"key":"1044_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82676-5","volume":"11","author":"KB Lin","year":"2021","unstructured":"Lin, K. B. et al. Lifestyle and behavioral modifications made by patients with interstitial cystitis. Sci. Rep. 11, 3055 (2021).","journal-title":"Sci. Rep."},{"key":"1044_CR184","doi-asserted-by":"publisher","first-page":"1079790","DOI":"10.3389\/fruro.2023.1079790","volume":"3","author":"BM Girard","year":"2023","unstructured":"Girard, B. M., Campbell, S. E. & Vizzard, M. A. Stress-induced symptom exacerbation: stress increases voiding frequency, somatic sensitivity, and urinary bladder NGF and BDNF expression in mice with subthreshold cyclophosphamide (CYP). Front. Urol. 3, 1079790 (2023).","journal-title":"Front. Urol."},{"key":"1044_CR185","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/1941738119886854","volume":"12","author":"B Khodadad","year":"2020","unstructured":"Khodadad, B., Letafatkar, A., Hadadnezhad, M. & Shojaedin, S. Comparing the effectiveness of cognitive functional treatment and lumbar stabilization treatment on pain and movement control in patients with low back pain. Sports Health 12, 289\u2013295 (2020).","journal-title":"Sports Health"},{"key":"1044_CR186","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1097\/j.pain.0000000000003188","volume":"165","author":"LC McKernan","year":"2024","unstructured":"McKernan, L. C. et al. A randomized-controlled pilot trial of telemedicine-delivered cognitive-behavioral therapy tailored for interstitial cystitis\/bladder pain syndrome. Pain 165, 1748\u20131760 (2024).","journal-title":"Pain"},{"key":"1044_CR187","doi-asserted-by":"publisher","first-page":"175628722211359","DOI":"10.1177\/17562872221135941","volume":"14","author":"B Padilla-Fern\u00e1ndez","year":"2022","unstructured":"Padilla-Fern\u00e1ndez, B., Hern\u00e1ndez-Hern\u00e1ndez, D. & Castro-D\u00edaz, D. M. Current role of neuromodulation in bladder pain syndrome\/interstitial cystitis. Ther. Adv. Urol. 14, 17562872221135941 (2022).","journal-title":"Ther. Adv. Urol."},{"key":"1044_CR188","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/nau.24242","volume":"39","author":"J Hui","year":"2020","unstructured":"Hui, J. et al. A novel, nonopiod-based treatment approach to men with urologic chronic pelvic pain syndrome using ultrasound-guided nerve hydrodissection and pelvic floor musculature trigger point injections. Neurourol. Urodyn. 39, 658\u2013664 (2020).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR189","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/nau.24799","volume":"41","author":"S Patil","year":"2022","unstructured":"Patil, S. et al. Neuromuscular treatment approach for women with chronic pelvic pain syndrome improving pelvic pain and functionality. Neurourol. Urodyn. 41, 220\u2013228 (2022).","journal-title":"Neurourol. Urodyn."},{"key":"1044_CR190","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/bco2.176","volume":"3","author":"S Patil","year":"2022","unstructured":"Patil, S. et al. Bladder pain syndrome\/interstitial cystitis response to nerve blocks and trigger point injections. BJUI Compass 3, 450\u2013457 (2022).","journal-title":"BJUI Compass"},{"key":"1044_CR191","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/luts.12334","volume":"13","author":"FC Chuang","year":"2021","unstructured":"Chuang, F. C., Yang, T. H. & Kuo, H. C. Botulinum toxin A injection in the treatment of chronic pelvic pain with hypertonic pelvic floor in women: treatment techniques and results. Low. Urin. Tract Symptoms 13, 5\u201312 (2021).","journal-title":"Low. Urin. Tract Symptoms"},{"key":"1044_CR192","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s00192-022-05115-7","volume":"33","author":"MA Spruijt","year":"2022","unstructured":"Spruijt, M. A., Klerkx, W. M., Kelder, J. C., Kluivers, K. B. & Kerkhof, M. H. The efficacy of botulinum toxin A injections in pelvic floor muscles in chronic pelvic pain patients: a systematic review and meta-analysis. Int. Urogynecol. J. 33, 2951\u20132961 (2022).","journal-title":"Int. Urogynecol. J."},{"key":"1044_CR193","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/luts.12364","volume":"13","author":"YH Jiang","year":"2021","unstructured":"Jiang, Y. H. et al. Urothelial health after platelet-rich plasma injection in intractable recurrent urinary tract infection: improved cell proliferation, cytoskeleton, and barrier function protein expression. Low. Urin. Tract Symptoms 13, 271\u2013278 (2021).","journal-title":"Low. Urin. Tract Symptoms"}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01044-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01044-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01044-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:02:23Z","timestamp":1759320143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01044-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":193,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1038\/s41585-025-01044-4","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"16 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}